Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients

The most widely studied and prescribed antiplatelet agent for the prevention of stroke and other serious vascular events among high vascular risk patients is aspirin. Aspirin inhibits platelet activation by inhibiting platelet cyclooxygenase and thromboxane production, and reduces the odds of a seri...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cochrane database of systematic reviews 2000 (2), p.CD001246-CD001246
Hauptverfasser:	Hankey, G J, Sudlow, C L, Dunbabin, D W
Format:	Artikel
Sprache:	eng
Schlagworte:	Aspirin - therapeutic use Cardiovascular Diseases - prevention & control Clopidogrel Fibrinolytic Agents - therapeutic use Humans Platelet Aggregation Inhibitors - therapeutic use Stroke - prevention & control Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!